Skip links
Companies
› France › BOIRON
Company registry profile
BOIRON logo

BOIRON

SA à conseil d'administration (société anonyme) Site closed (2020); company active

This page covers one establishment of BOIRON. It is not a separate company. The SIRET number 967 504 697 00673 identifies BOIRON’s site at 18 rue de l’Innovation, 42000 Saint-Étienne, France. In the INSEE Sirene register this establishment was created on 27 August 2001. It replaced an earlier Saint-Étienne establishment at 24 rue de la Télématique, which operated from 1988 to 2001. The site is recorded as closed (fermé) since 7 February 2020. It was not the registered office.

The legal entity is BOIRON, a French société anonyme à conseil d’administration (an SA with a board of directors). Its SIREN is 967 504 697 and it is registered with the RCS Lyon. Sirene gives the legal unit a creation date of 1 January 1967, and GLEIF records the same date (LEI 9695000UMPNY21KKDO98). The laboratories themselves were founded in 1932 by the pharmacists Jean and Henri Boiron. The legal unit is active. Its registered office is at 2 avenue de l’Ouest Lyonnais, 69510 Messimy, and its main activity code is NAF 21.20Z (manufacture of pharmaceutical preparations). On 22 October 2026 Sirene listed 98 establishments for the SIREN, 14 of them open. So the closed status on this page describes the Saint-Étienne site, not the company.

BOIRON develops, manufactures and distributes homeopathic medicines. These include common-name products sold as granules and globules, branded homeopathic specialities for self-medication, and other health products such as medical devices, food supplements, herbal products and cosmetics. According to its 2025 annual financial report, BOIRON supplies about 20,000 French pharmacies through eleven distribution establishments, operates in about fifty countries, and made 59% of its 2025 sales outside France. Its shares trade on Euronext Paris under the ticker BOI (ISIN FR0000061129).

Consolidated BOIRON group revenue for 2025 was €501.1 million, up 2.8%, and group-share net profit was €32.6 million. At the level of the legal entity alone, BOIRON SA reported 2025 revenue of €335.2 million and a net loss of €0.33 million, with an average of 1,685 full-time-equivalent employees. The group as a whole had 2,634 employees at the end of 2025, 1,725 of them in France. In the first half of 2026, group-share net profit was €4.9 million and revenue was 0.3% lower at constant exchange rates.

Recent changes to the French network: a reorganisation presented on 21 November 2024 led to the closure of four establishments and seven preparation units in the second half of 2025, and the Antibes (Sophia Antipolis) site was sold in the first half of 2026. The closure of the Saint-Étienne site in February 2020 came before the restructuring plan announced in March 2020. None of the filings reviewed gives a reason for it.

Sources:

  • recherche-entreprises.api.gouv.fr (INSEE Sirene / RNE), legal unit: https://recherche-entreprises.api.gouv.fr/search?q=967504697. Record updated 21 Oct 2026, retrieved 22 Oct 2026.
  • recherche-entreprises.api.gouv.fr, establishment SIRET 96750469700673 and the Loire establishments: https://recherche-entreprises.api.gouv.fr/search?q=96750469700673 and https://recherche-entreprises.api.gouv.fr/search?q=boiron&departement=42, retrieved 22 Oct 2026.
  • BOIRON, Rapport financier annuel 2025: https://www.boironfinance.fr/files/Rapport%20financier%20-%20Donn%C3%A9es%20annuelles/Rapport%20Financier%20Annuel%202025.pdf. Published 2026, retrieved 22 Oct 2026.
  • BOIRON, Chiffre d’affaires et résultats 2025, 2 Apr 2026 (AMF/DILA copy): https://echanges.dila.gouv.fr/OPENDATA/AMF/ACT/2026/04/FCACT078975_20260402.pdf, retrieved 22 Oct 2026.
  • BOIRON, Rapport financier semestriel 2026, 17 Sep 2026: https://www.boironfinance.fr/files/Rapport%20financier%20-%20Donn%C3%A9es%20semestrielles/2026/Rapport%20semestriel%202026.pdf, retrieved 22 Oct 2026.
  • GLEIF LEI record: https://api.gleif.org/api/v1/lei-records/9695000UMPNY21KKDO98. Last updated 30 Oct 2025, retrieved 22 Oct 2026.
  • boiron.fr, Conditions générales d’utilisation (legal notice naming RCS Lyon 967 504 697): https://www.boiron.fr/conditions-generales-dutilisation, retrieved 22 Oct 2026.

From the registry

Registration details

Registration No.
SIREN 967 504 697 (RCS Lyon); Saint-Étienne site SIRET 967 504 697 00673
Incorporation Date
1 January 1967 (founded 1932)
Company Type
SA à conseil d'administration (société anonyme)
Address
Registered office: 2 avenue de l'Ouest Lyonnais, 69510 Messimy, France
Website
www.boiron.fr/
Source: INSEE Sirene, BODACC, GLEIF and BOIRON 2025 annual report — checked 22 Oct 2026Registry coverage

Shareholders

Shareholders of BOIRON

A closed establishment such as the Saint-Étienne site (SIRET 96750469700673) has no shareholders of its own. Ownership sits with the legal entity, BOIRON SA (SIREN 967 504 697), a listed company on Euronext Paris. The figures below are what that company disclosed in its 2025 annual financial report.

At 31 December 2025 the company’s capital was 17,545,408 shares, divided as follows:

  • BOIRON DÉVELOPPEMENT, a French SAS, held 79.0% of the capital and 78.6% of the voting rights (excluding treasury shares). It is the only shareholder above the two-thirds threshold.
  • ORFIM, a French investment SAS, is disclosed as holding more than 5% of both capital and voting rights. The report gives no exact percentage.
  • BOIRON held 183,133 of its own shares (1.04%) as treasury shares.
  • Other shareholders held about 20.0%.

The current structure dates from 20 October 2023. On that date the members of the Boiron family concert and the FCPE BOIRON employee fund contributed or sold their 13,257,978 BOIRON shares to BOIRON DÉVELOPPEMENT. Those shares were 75.56% of the capital. BOIRON DÉVELOPPEMENT then made a simplified public tender offer, which the AMF declared compliant on 9 January 2024 and which ran from 11 to 31 January 2024. At the close of the offer it held 78.98% of the capital, which was not enough for a squeeze-out, so the shares remain listed. The company reports no other significant change in its shareholding during 2025 or since 31 December 2025.

Under the company’s double-voting-right rules, total voting rights on 30 September 2026 were 18,505,779 gross and 18,322,646 net. Both figures are higher than the 17,545,408 shares in issue.

Ultimate beneficial ownership

The 2025 annual financial report states that BOIRON DÉVELOPPEMENT is controlled by the “concert familial BOIRON”. That concert consists of the family holding companies SODEVA and SHB, members of the Boiron family, EW HEALTHCARE PARTNERS through the fund DOMINO FUND 3 HOLDCO GP LLC, and the FCPE BOIRON. The report adds that BOIRON remains indirectly controlled by the family holding companies SODEVA and SHB.

The filings do not publish the percentage each member holds in BOIRON DÉVELOPPEMENT, or who owns SODEVA and SHB. An effective ownership percentage therefore cannot be calculated for any natural person, and no individual beneficial owner is named here.

Data availability

Availability is major shareholders only. As a listed issuer, BOIRON must disclose holdings that cross the statutory thresholds starting at 5%. The full share register is not public. The French register of beneficial owners (RBE) has been closed to the general public since November 2022, so the ownership chain above BOIRON DÉVELOPPEMENT could not be checked against it.

Sources

  • BOIRON, Rapport financier annuel 2025, §1.7.2 “Principaux actionnaires” and “Offre Publique d’Achat”: https://www.boironfinance.fr/files/Rapport%20financier%20-%20Donn%C3%A9es%20annuelles/Rapport%20Financier%20Annuel%202025.pdf. Information at 31 Dec 2025, retrieved 22 Oct 2026.
  • BOIRON, Publication du nombre d’actions et de droits de vote au 30 septembre 2026 (published 9 Oct 2026): https://www.boironfinance.fr/files/d%C3%A9claration%20mensuelle%20des%20droits%20de%20vote/D%C3%A9claration%20des%20droits%20de%20vote%20au%2030%20septembre%202026.pdf, retrieved 22 Oct 2026.
  • recherche-entreprises.api.gouv.fr, establishment SIRET 96750469700673: https://recherche-entreprises.api.gouv.fr/search?q=96750469700673, retrieved 22 Oct 2026.

Officers

Directors and officers of BOIRON

French registers record officers against the legal entity, BOIRON SA (SIREN 967 504 697). They do not record officers for an establishment such as the closed Saint-Étienne site (SIRET 96750469700673). This block therefore describes the management of the company.

BOIRON is a société anonyme with a board of directors, and the roles of chairman and chief executive are held by different people. The board has had thirteen members since the general meeting of 23 May 2024. They include one director representing employee shareholders and two directors representing employees. According to the BODACC notices, the current officers are:

  • Anabelle Flory-Boiron, Chairman of the Board (Président du conseil d’administration). The BODACC notice recording this was published on 20 October 2024.
  • Pascal Houdayer, Chief Executive (Directeur général) from 1 January 2025. He has also been a director since 2025.
  • Frédéric Riou, Deputy Chief Executive (Directeur général délégué) and Pharmacien responsable (responsible pharmacist) from 1 June 2025.

Three companies sit on the board as corporate directors. Each acts through a permanent representative, as listed in the 2025 report:

  • BOIRON DÉVELOPPEMENT (SIREN 953 894 037), represented by Laurence Boiron.
  • DOMINO FUND 3 HOLDCO GP LLC, a company incorporated outside France, represented by Evis Hursever.
  • FIDENTIS, represented by Philippe Brun. FIDENTIS is classed as independent.

The statutory auditors are FORVIS MAZARS and GRANT THORNTON. Grant Thornton replaced Deloitte & Associés, as published in BODACC on 19 October 2023. The registers do not record nationality for these officers, so it is not disclosed here.

Recent officer changes

  • 31 December 2025: Thierry Boiron left his role as Deputy Chief Executive. He remains a director of BOIRON (BODACC notice published 16 January 2026; 2025 annual financial report).
  • 1 June 2025: Frédéric Riou became Deputy Chief Executive and responsible pharmacist, replacing Jean-Christophe Bayssat, who retired (BODACC notice published 15 June 2025).
  • 1 January 2025: Pascal Houdayer became Chief Executive, replacing Thierry Boiron. The board had appointed him on 11 December 2024 (BODACC notices published 9 and 14 February 2025).

Data availability

Availability is full for the legal entity: BODACC publishes a dated notice each time the administration changes, and the annual report lists every board seat. The consolidated list in the RNE / recherche-entreprises service is out of date. On 22 October 2026 it still named Jean-Christophe Bayssat as Deputy Chief Executive, although he left on 31 May 2025, so the dated BODACC notices were used instead. Nationality is not published in these sources.

Sources

  • BODACC notice, 16 Jan 2026: https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B2026001012084, retrieved 22 Oct 2026.
  • BODACC notice, 15 Jun 2025: https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202501131485, retrieved 22 Oct 2026.
  • BODACC notices, 9 and 14 Feb 2025: https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202500283312 and https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202500321565, retrieved 22 Oct 2026.
  • BODACC notice, 20 Oct 2024: https://www.bodacc.fr/pages/annonces-commerciales-detail/?q.id=id:B202402041955, retrieved 22 Oct 2026.
  • BOIRON, Rapport financier annuel 2025 (corporate governance report): https://www.boironfinance.fr/files/Rapport%20financier%20-%20Donn%C3%A9es%20annuelles/Rapport%20Financier%20Annuel%202025.pdf, retrieved 22 Oct 2026.
  • recherche-entreprises.api.gouv.fr, legal unit 967504697: https://recherche-entreprises.api.gouv.fr/search?q=967504697, retrieved 22 Oct 2026.

Group Structure

Group structure of BOIRON

The Saint-Étienne site (SIRET 96750469700673) was a branch-type establishment of BOIRON SA (SIREN 967 504 697), not a subsidiary. It was part of the same legal person and has been closed since 7 February 2020. BOIRON SA is the parent of the BOIRON group.

The immediate parent is BOIRON DÉVELOPPEMENT SAS (SIREN 953 894 037). It was created on 27 June 2023 and shares BOIRON’s registered office in Messimy. It held 78.98% of BOIRON’s capital at 31 December 2025. The 2025 annual financial report describes it as the group’s lead holding company (“holding animatrice”) and says it consolidates BOIRON in its own accounts. The report places control of BOIRON DÉVELOPPEMENT with a family-led concert, which includes the family holding companies SODEVA and SHB. Ownership percentages above BOIRON DÉVELOPPEMENT are not published.

BOIRON SA fully consolidates 25 subsidiaries. They are in Belgium, Italy, the United States, Spain, Canada, the French overseas departments (Martinique and La Réunion), the Czech Republic, Slovakia, Poland, Romania, Tunisia, Hungary, Russia, Brazil, Switzerland, Bulgaria, Portugal, India, Colombia, Hong Kong and China. Most are held at 99–100%. One is indirect: BOIRON (HANGZHOU) TRADING is wholly owned through BOIRON ASIA LIMITED.

Verified corporate relationships

Entity Country Registration number Relationship Ownership Status Information date
BOIRON DÉVELOPPEMENT France SIREN 953 894 037 Immediate parent 78.98% of capital; 78.6% of voting rights Active 31 Dec 2025
BOIRON, Saint-Étienne establishment France SIRET 967 504 697 00673 Establishment (branch) of BOIRON SA Same legal person Closed 7 Feb 2020 22 Oct 2026
BOIRON USA United States Not stated in source Subsidiary (holding company) 100% interest Consolidated 31 Dec 2025
BOIRON (US operating company) United States Not stated in source Subsidiary 100% interest Consolidated 31 Dec 2025
LABORATOIRES BOIRON Italy Not stated in source Subsidiary 99.91% interest; 99.97% control Consolidated 31 Dec 2025
UNDA Belgium Not stated in source Subsidiary 99.98% interest Consolidated 31 Dec 2025
BOIRON SOCIEDAD IBERICA DE HOMEOPATIA Spain Not stated in source Subsidiary 99.99% interest; 100% control Consolidated 31 Dec 2025
BOIRON CANADA Canada Not stated in source Subsidiary 100% interest Consolidated 31 Dec 2025
BOIRON CARAIBES France (Martinique) Not stated in source Subsidiary 99.04% interest Consolidated 31 Dec 2025
LES EDITIONS SIMILIA France Not stated in source Subsidiary (publishing) 97.59% interest Consolidated 31 Dec 2025
BOIRON ASIA LIMITED Hong Kong Not stated in source Subsidiary 100% interest Consolidated 31 Dec 2025
BOIRON (HANGZHOU) TRADING Co., Ltd China Not stated in source Indirect subsidiary (via BOIRON ASIA LIMITED) 100% interest Consolidated 31 Dec 2025
BOIRON LABORATORIES India Not stated in source Subsidiary 99.99% interest In liquidation; due to leave the consolidation scope in 2026 31 Dec 2025

The other consolidated subsidiaries are BOIRON CZ, BOIRON SK, BOIRON SP (Poland), BOIRON RO, BOIRON TN (Tunisia), BOIRON HUNGARIA, BOIRON (Russia), BOIRON MEDICAMENTOS HOMEOPATICOS (Brazil), BOIRON (Switzerland), BOIRON OCEAN INDIEN, BOIRON BG, BOIRON (Portugal), BOIRON (Belgium) and BOIRON S.A.S. (Colombia). The interest in each is 99.9–100%. Not every subsidiary is owned directly by BOIRON SA: the report gives a percentage interest for each but not every holding chain. “% interest” is the consolidated interest reported in the accounts.

Recent structural changes

  • 1 October 2026 (proposed, not completed): BOIRON entered exclusive negotiations to acquire 100% of Hivital Labs, a food-supplement business based in Barcelona. The deal is subject to consultation of the central works council and to the required authorisations. Definitive agreements could be signed in the fourth quarter of 2026.
  • 14 June 2024: BOIRON SA agreed to sell its entire holding in ABBI to SAGAD.
  • 3 September 2024: BOIRON SA, BOIRON ASIA and HK CALENDULA MANAGEMENT signed a shareholders’ agreement. It includes a put option, with a matching obligation on BOIRON SA to buy back the BOIRON ASIA shares held by HK CALENDULA MANAGEMENT, on a 2030 horizon.

Data availability

Availability is partial. The consolidation scope gives names, countries and percentage interest, but no registration numbers. It covers consolidated entities only, so non-consolidated holdings are not listed. Ownership percentages above BOIRON DÉVELOPPEMENT are not public.

Sources

  • BOIRON, Rapport financier annuel 2025, consolidated accounts note 3 “Périmètre de consolidation” and corporate governance report: https://www.boironfinance.fr/files/Rapport%20financier%20-%20Donn%C3%A9es%20annuelles/Rapport%20Financier%20Annuel%202025.pdf. Information at 31 Dec 2025, retrieved 22 Oct 2026.
  • BOIRON, “Les Laboratoires Boiron entrent en négociation exclusive en vue de l’acquisition de Hivital Labs”, 1 Oct 2026: https://www.boironfinance.fr/files/Actualit%C3%A9s/Communique%20n%C3%A9gociation%20exclusive%20Hivital%20Labs.pdf, retrieved 22 Oct 2026.
  • recherche-entreprises.api.gouv.fr, BOIRON DÉVELOPPEMENT 953894037: https://recherche-entreprises.api.gouv.fr/search?q=953894037, retrieved 22 Oct 2026.
  • recherche-entreprises.api.gouv.fr, establishment SIRET 96750469700673: https://recherche-entreprises.api.gouv.fr/search?q=96750469700673, retrieved 22 Oct 2026.

Registry questions

Frequently asked questions

What does BOIRON do?

This page is the Saint-Étienne establishment (SIRET 96750469700673) of BOIRON SA, SIREN 967 504 697, RCS Lyon; the establishment has been closed since 7 February 2020, while the legal entity is active. BOIRON develops, manufactures and distributes homeopathic medicines and other health products (NAF 21.20Z), with its registered office in Messimy.

Who owns BOIRON?

At 31 December 2025 BOIRON DÉVELOPPEMENT SAS held 79.0% of BOIRON SA capital and 78.6% of voting rights, ORFIM held more than 5% (exact figure not published), treasury shares were 1.04% and other shareholders about 20%.

Who is BOIRON's UBO (Ultimate Beneficial Owner)?

No individual beneficial owner is named in the filings. The 2025 annual financial report says BOIRON DÉVELOPPEMENT is controlled by the Boiron family concert (SODEVA, SHB and Boiron family members), EW Healthcare Partners via Domino Fund 3 Holdco GP LLC and the FCPE BOIRON, without giving each member’s percentage; the French beneficial-owner register is not public.

What is BOIRON's company registration number?

BOIRON SA is registered with the RCS Lyon under SIREN 967 504 697 (LEI 9695000UMPNY21KKDO98). This page covers its former Saint-Étienne establishment, SIRET 967 504 697 00673, which is a site of that company rather than a separate one.

Is BOIRON still an active company?

BOIRON SA is an active company, but the Saint-Étienne establishment covered by this page has been closed (fermé) in the INSEE Sirene register since 7 February 2020. On 22 October 2026 Sirene listed 98 establishments for the company, 14 of them open.

When was BOIRON incorporated?

Sirene and GLEIF both give the legal unit BOIRON a creation date of 1 January 1967; the laboratories themselves were founded in 1932 by the pharmacists Jean and Henri Boiron. The Saint-Étienne establishment was created on 27 August 2001.

What is BOIRON's registered address?

BOIRON's registered office is at 2 avenue de l'Ouest Lyonnais, 69510 Messimy. The closed establishment on this page was at 18 rue de l'Innovation, 42000 Saint-Étienne, and was never the registered office.

What legal structure is BOIRON registered as?

BOIRON is a French société anonyme à conseil d'administration, a public limited company with a board of directors, in which the chairman and chief executive roles are held by different people.

What is BOIRON's revenue?

BOIRON group consolidated revenue was €501.1 million in 2025, with group-share net profit of €32.6 million. The legal entity BOIRON SA alone reported 2025 revenue of €335.2 million and a net loss of €0.33 million (2025 annual financial report).

Is BOIRON listed on a stock exchange?

BOIRON SA shares are listed on Euronext Paris under the ticker BOI (ISIN FR0000061129); a closed establishment has no listing of its own.

Who are the officers/directors of BOIRON?

Per BODACC notices, Anabelle Flory-Boiron chairs the board, Pascal Houdayer has been Chief Executive since 1 January 2025 and Frédéric Riou Deputy Chief Executive since 1 June 2025; Thierry Boiron left the Deputy Chief Executive role on 31 December 2025 and remains a director.

Does BOIRON have a parent company or subsidiaries?

BOIRON SA is directly controlled by BOIRON DÉVELOPPEMENT SAS (SIREN 953 894 037, 78.98% of capital) and heads a group of 25 fully consolidated subsidiaries in Europe, the Americas and Asia. The Saint-Étienne site was an establishment of BOIRON SA, not a subsidiary.

How did BOIRON DÉVELOPPEMENT become BOIRON's majority shareholder?

On 20 October 2023 the Boiron family concert and the FCPE BOIRON employee fund contributed or sold their 13,257,978 shares (75.56% of capital) to BOIRON DÉVELOPPEMENT. Its simplified tender offer, run from 11 to 31 January 2024, took it to 78.98%, too little for a squeeze-out, so BOIRON stays listed.

Who controls BOIRON DÉVELOPPEMENT, BOIRON's parent?

The 2025 annual financial report says it is controlled by the Boiron family concert: the family holding companies SODEVA and SHB, Boiron family members, EW Healthcare Partners through Domino Fund 3 Holdco GP LLC, and the FCPE BOIRON. BOIRON remains indirectly controlled by SODEVA and SHB, whose own owners are not published.

Why do BOIRON's voting rights exceed its number of shares?

BOIRON has double voting rights. On 30 September 2026 its total voting rights were 18,505,779 gross and 18,322,646 net, against 17,545,408 shares in issue.

Which BOIRON subsidiaries are not held directly by BOIRON SA?

BOIRON (HANGZHOU) TRADING in China is wholly owned through BOIRON ASIA LIMITED of Hong Kong. A shareholders' agreement of 3 September 2024 gives HK CALENDULA MANAGEMENT a put option, on a 2030 horizon, over the BOIRON ASIA shares it holds.

Is BOIRON buying or selling any businesses?

On 1 October 2026 BOIRON entered exclusive negotiations to acquire 100% of Hivital Labs, a Barcelona food-supplement business; the deal was not completed. In June 2024 BOIRON SA agreed to sell its whole holding in ABBI to SAGAD.

Can Zavia monitor changes to BOIRON's ownership over time?

This profile reflects a point-in-time snapshot. Zavia's monitoring API can track changes to BOIRON's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access BOIRON's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including France, so records like BOIRON's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

Checked against INSEE Sirene, BODACC, GLEIF and BOIRON's 2025 annual and 2026 half-year financial reports on 22 October 2026.

This website uses cookies to improve your web experience.